Elk1 and SRF transcription factors convey basal transcription and mediate glucose response via their binding sites in the human LXRB gene promoter

Nucleic Acids Research

Volumn 35, Issue 14, 2007, Pages 4858-4868

  Nilsson, Maria ^a   Dahlman Wright, Karin ^a   Karelmo, Charlotta ^a   Gustafsson, Jan Åke ^a   Steffensen, Knut R ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CHOLESTEROL; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; SERUM RESPONSE FACTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ELK 1;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CARDIOVASCULAR DISEASE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG TARGETING; GENE MUTATION; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CONSERVED SEQUENCE; DNA-BINDING PROTEINS; ETS-DOMAIN PROTEIN ELK-1; GLUCOSE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECEPTORS, CYTOPLASMIC AND NUCLEAR; SERUM RESPONSE FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 34547885457     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm492     Document Type: Article

References (26)

1. Shulman,A.I. and Mangelsdorf,D.J. (2005) Retinoid x receptor heterodimers in the metabolic syndrome. N. Engl. J. Med., 353 604-615.
2. Steffensen,K.R. and Gustafsson,J.-Å. (2006) Liver X receptors: New drug targets to treat Type 2 diabetes? Future Lipidol, 1, 181-189.
3. Uyeda,K. and Repa,J.J. (2006) Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab., 4, 107-110.
4. Cha,J.Y. and Repa,J.J. (2007) The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J. Biol. Chem., 282, 743-751.
5. Mitro,N., Mak,P.A., Vargas,L., Godio,C., Hampton,E., Molteni,V., Kreusch,A. and Saez,E. (2007) The nuclear receptor LXR is a glucose sensor. Nature, 445, 219-223.
6. Kase,E.T., Wensaas,A.J., Aas,V., Hojlund,K., Levin,K., Thoresen,G.H., Beck-Nielsen,H., Rustan,A.C. and Gaster,M. (2005) Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes, 54, 1108-1115.
7. Dalen,K.T., Ulven,S.M., Bamberg,K., Gustafsson,J.-Å. and Nebb,H.I. (2003) Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha. J. Biol. Chem., 278, 48283-48291.
8. Laffitte,B.A., Chao,L.C., Li,J., Walczak,R., Hummasti,S., Joseph,S.B., Castrillo,A., Wilpitz,D.C., Mangelsdorf,D.J. et al. (2003) Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. USA, 100, 5419-5424.
9. Cao,G., Liang,Y., Broderick,C.L., Oldham,B.A., Beyer,T.P., Schmidt,R.J., Zhang,Y., Stayrook,K.R., Suen,C. et al. (2003) Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. J. Biol. Chem., 278, 1131-1136.
10. Efanov,A.M., Sewing,S., Bokvist,K. and Gromada,J. (2004) Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes, 53 (Suppl. 3), S75-S78.
11. Loffler,M., Bilban,M., Reimers,M., Waldhausl,W. and Stulnig,T. (2005) Blood glucose lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice. J. Pharmacol. Exp. Ther., 316, 797-804.
12. Gerin,I., Dolinsky,V.W., Shackman,J.G., Kennedy,R.T., Chiang,S.H., Burant,C.F., Steffensen,K.R., Gustafsson,J.-Å. and Macdougald,O.A. (2005) LXR{beta} Is Required for adipocyte growth, glucose homeostasis, and {beta) cell function. J. Biol. Chem., 280, 23024-23031.
13. Grefhorst,A., van Dijk,T.H., Hammer,A., van der Sluijs,F.H., Havinga,R., Havekes,L.M., Romijn,J.A., Groot,P.H., Reijngoud,D.J. et al. (2005) Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ ob mice. Am. J. Physiol. Endocrinol. Metab., 289, E829-E838.
14. Chisholm,J.W., Hong,J., Mills,S.A. and Lawn,R.M. (2003) The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J. Lipid. Res., 44, 2039-2048.
15. Yordy,J.S. and Muise-Helmericks,R.C. (2000) Signal transduction and the Ets family of transcription factors. Oncogene, 19, 6503-6513.
16. Posern,G. and Treisman,R. (2006) Actin' together: Serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 16, 588-596.
17. Alberti,S., Steffensen,K.R. and Gustafsson,J.-Å. (2000) Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta. Gene, 243, 93-103.
18. Sandberg,M.B., Fridriksson,J., Madsen,L., Rishi,V., Vinson,C., Holmsen,H., Berge,R.K. and Mandrup,S. (2005) Glucose-induced lipogenesis in pancreatic beta-cells is dependent on SREBP-1. Mol. Cell Endocrinol., 240, 94-106.
19. Bernal-Mizrachi,E., Wen,W., Srinivasan,S., Klenk,A., Cohen,D. and Permutt,M.A. (2001) Activation of Elk-1, an Ets transcription factor, by glucose and EGF treatment of insulinoma cells. Am. J. Physiol. Endocrinol. Metab., 281, E1286-E1299.
20. Xi,X.P., Graf,K., Goetze,S., Hsueh,W.A. and Law,R.E. (1997) Inhibition of MAP kinase-blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett., 417, 283-286.
21. Vickers,E.R., Kasza,A., Kurnaz,I.A., Seifert,A., Zeef,L.A., O'Donnell,A., Hayes,A. and Sharrocks,A.D. (2004) Ternary complex factor-serum response factor complex-regulated gene activity is required for cellular proliferation and inhibition of apoptotic cell death. Mol. Cell Biol., 24, 10340-10351.
22. Mulholland,D.J., Dedhar,S., Coetzee,G.A. and Nelson,C.C. (2005) Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr. Rev., 26, 898-915.
23. Wente,W., Brenner,M.B., Zitzer,H., Gromada,J. and Efanov,A.M. (2006) Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin secreting cells. Endocrinology, 148, 1843-1849.
24. Blaschke,F., Leppanen,O., Takata,Y., Caglayan,E., Liu,J., Fishbein,M.C., Kappert,K., Nakayama,K.I., Collins,A.R. et al. (2004) Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ. Res., 95, e110-e123.
25. Fukuchi,J., Kokontis,J.M., Hiipakka,R.A., Chuu,C.P. and Liao,S. (2004) Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res., 64, 7686-7689.
26. Vigushin,D.M., Dong,Y., Inman,L., Peyvandi,N., Alao,J.P., Sun,C., Ali,S., Niesor,E.J., Bentzen,C.L. et al. (2004) The nuclear oxysterol receptor LXRalpha is expressed in the normal human breast and in breast cancer. Med. Oncol., 21, 123-131.